General MM

How significant is the role of MRD status in MM, and how can we best utilize this information?

L: English

The Multiple Myeloma Hub is pleased to present a series of expert interviews from the 61st American Society of Hematology (ASH) meeting in Orlando, US. In this video, Bruno Paiva, University of Navarra, Pamplona, ES, answers the question: How significant is the role of minimal residual disease status in myeloma becoming, and how can we best utilize this information?

Bruno Paiva states that minimal residual disease is the most powerful prognostic marker in myeloma and describes the importance of the role of minimal residual disease status in determining the prognosis of multiple myeloma.